BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22149676)

  • 1. Oligomerization preceding amyloid fibril formation: a process in common to intrinsically disordered and globular proteins.
    Zerovnik E
    Network; 2011; 22(1-4):154-61. PubMed ID: 22149676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of amyloid-β fibril elongation.
    Gurry T; Stultz CM
    Biochemistry; 2014 Nov; 53(44):6981-91. PubMed ID: 25330398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid fibril formation by human stefins: Structure, mechanism & putative functions.
    Zerovnik E; Staniforth RA; Turk D
    Biochimie; 2010 Nov; 92(11):1597-607. PubMed ID: 20685229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and intermolecular dynamics of aggregates populated during amyloid fibril formation studied by hydrogen/deuterium exchange.
    Carulla N; Zhou M; Giralt E; Robinson CV; Dobson CM
    Acc Chem Res; 2010 Aug; 43(8):1072-9. PubMed ID: 20557067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of soluble amyloid oligomers from computer simulations.
    Melquiond A; Mousseau N; Derreumaux P
    Proteins; 2006 Oct; 65(1):180-91. PubMed ID: 16894607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural models of amyloid-like fibrils.
    Nelson R; Eisenberg D
    Adv Protein Chem; 2006; 73():235-82. PubMed ID: 17190616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Native globular and native partially or completely disordered proteins. Folding, supramolecular complex formation and aggregation].
    Turoverov KK; Uverskiĭ VN; Kuznetsova IM
    Tsitologiia; 2009; 51(3):190-203. PubMed ID: 19435273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of kinetic pathways in amyloid fibril formation.
    Bellesia G; Shea JE
    J Chem Phys; 2009 Sep; 131(11):111102. PubMed ID: 19778093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.
    Lai Z; Colón W; Kelly JW
    Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the mysteries of protein folding and misfolding.
    Ecroyd H; Carver JA
    IUBMB Life; 2008 Dec; 60(12):769-74. PubMed ID: 18767168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation.
    Bader R; Bamford R; Zurdo J; Luisi BF; Dobson CM
    J Mol Biol; 2006 Feb; 356(1):189-208. PubMed ID: 16364365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-structure correlation in protein space unveils different selection rules for folded and intrinsically disordered proteins.
    Naranjo Y; Pons M; Konrat R
    Mol Biosyst; 2012 Jan; 8(1):411-6. PubMed ID: 22108787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the mechanism of formation of native-like and precursor amyloid oligomers for the native acylphosphatase from Sulfolobus solfataricus.
    Plakoutsi G; Bemporad F; Monti M; Pagnozzi D; Pucci P; Chiti F
    Structure; 2006 Jun; 14(6):993-1001. PubMed ID: 16765892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
    J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energy barriers for HET-s prion forming domain amyloid formation.
    Sabaté R; Castillo V; Espargaró A; Saupe SJ; Ventura S
    FEBS J; 2009 Sep; 276(18):5053-64. PubMed ID: 19682303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting the aggregation kinetics of amyloid peptides.
    Pellarin R; Caflisch A
    J Mol Biol; 2006 Jul; 360(4):882-92. PubMed ID: 16797587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids enhance apolipoprotein C-II-derived amyloidogenic peptide oligomerization but inhibit fibril formation.
    Hung A; Griffin MD; Howlett GJ; Yarovsky I
    J Phys Chem B; 2009 Jul; 113(28):9447-53. PubMed ID: 19537801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships.
    Bemporad F; Chiti F
    Chem Biol; 2012 Mar; 19(3):315-27. PubMed ID: 22444587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.